Literature DB >> 24034655

Masked hypertension defined by home blood pressure monitoring is associated with impaired flow-mediated vasodilatation in patients with cardiovascular risk factors.

Tomoyuki Kabutoya1, Satoshi Hoshide, Yukiyo Ogata, Kazuo Eguchi, Kazuomi Kario.   

Abstract

The relationships between home blood pressure (BP), masked hypertension defined by home BP, and integrated flow-mediated vasodilation (FMD) response remain unclear. The authors enrolled 257 patients (mean age, 63.5 years; 51% men) who had at least one cardiovascular risk factor. FMD of the brachial artery was measured with a semiautomatic edge-detection algorithm. The integrated FMD response was calculated as the area under the dilation curve during 120 seconds after deflation (FMD-AUC120) and the FMD magnitude as the percentage change in peak diameter (ΔFMD). Masked hypertension was defined by office BP <140/90 mm Hg and home BP ≥135 mm Hg and/or 85 mm Hg. Home systolic BP was inversely correlated with FMD-AUC120 and ΔFMD (FMD-AUC120: r=-.23, P<.001; ΔFMD: r=-.13, P=.041), and office systolic BP was inversely associated with FMD-AUC120 (r=-.16, P=.011), but not with ΔFMD. After adjusting for covariates, home systolic BP (β=-.27, P=.003), but not office BP, was inversely associated with FMD-AUC120, whereas ΔFMD was not associated with office or home systolic BP. FMD-AUC120 was significantly lower in patients with masked hypertension compared with those with normotension (7.7±6.7 vs 11.5±8.8 mm × s, P=.048). Home systolic BP and masked hypertension defined by home BP were associated with a decrease in FMD-AUC120. ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24034655      PMCID: PMC8033951          DOI: 10.1111/jch.12155

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  39 in total

1.  Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study.

Authors:  Teemu J Niiranen; Marjo-Riitta Hänninen; Jouni Johansson; Antti Reunanen; Antti M Jula
Journal:  Hypertension       Date:  2010-04-12       Impact factor: 10.190

Review 2.  Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review.

Authors:  George S Stergiou; Ioannis A Bliziotis
Journal:  Am J Hypertens       Date:  2010-09-09       Impact factor: 2.689

3.  Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation.

Authors:  Ann E Donald; Julian P Halcox; Marietta Charakida; Clare Storry; Sharon M L Wallace; Tim J Cole; Peter Friberg; John E Deanfield
Journal:  J Am Coll Cardiol       Date:  2008-05-20       Impact factor: 24.094

4.  Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study.

Authors:  Kageumi Takeno; Tomoya Mita; Shiho Nakayama; Hiromasa Goto; Koji Komiya; Hiroko Abe; Fuki Ikeda; Tomoaki Shimizu; Akio Kanazawa; Takahisa Hirose; Ryuzo Kawamori; Hirotaka Watada
Journal:  Am J Hypertens       Date:  2011-11-17       Impact factor: 2.689

5.  When and how to use self (home) and ambulatory blood pressure monitoring.

Authors:  Thomas G Pickering; William B White; Thomas D Giles; Henry R Black; Joseph L Izzo; Barry J Materson; Suzanne Oparil; Michael A Weber
Journal:  J Am Soc Hypertens       Date:  2010 Mar-Apr

6.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

7.  Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers.

Authors:  K Kario; T Matsuo; H Kobayashi; M Imiya; M Matsuo; K Shimada
Journal:  Hypertension       Date:  1996-01       Impact factor: 10.190

Review 8.  What is the role of non-invasive measurements of atherosclerosis in individual cardiovascular risk prediction?

Authors:  Ewoud Ter Avest; Anton F H Stalenhoef; Jacqueline de Graaf
Journal:  Clin Sci (Lond)       Date:  2007-05       Impact factor: 6.124

9.  Morning hypertension assessed by home monitoring is a strong predictor of concentric left ventricular hypertrophy in patients with untreated hypertension.

Authors:  Yoshio Matsui; Kazuo Eguchi; Seiichi Shibasaki; Joji Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-10       Impact factor: 3.738

10.  Masked hypertension defined by home blood pressure monitoring is associated with impaired flow-mediated vasodilatation in patients with cardiovascular risk factors.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-25       Impact factor: 3.738

View more
  8 in total

1.  Endothelial function in postmenopausal women with nighttime systolic hypertension.

Authors:  Faye S Routledge; Alan L Hinderliter; Judith McFetridge-Durdle; James A Blumenthal; Nicola J Paine; Andrew Sherwood
Journal:  Menopause       Date:  2015-08       Impact factor: 2.953

Review 2.  Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Apichard Sukonthasarn; Yuda Turana; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yu-Qing Zhang; Sungha Park; Huynh Van Minh; Naoko Tomitani; Tomoyuki Kabutoya; Narsingh Verma; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-26       Impact factor: 3.738

3.  The effects of topiroxostat on vascular function in patients with hyperuricemia.

Authors:  Shingo Higa; Daisuke Shima; Naoko Tomitani; Yoko Fujimoto; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-26       Impact factor: 3.738

4.  Prevalence of masked hypertension in African Americans.

Authors:  Timothy R Larsen; Alehegn Gelaye; Barryton Waanbah; Hadeel Assad; Yara Daloul; Frances Williams; Michael Williams; Susan Steigerwalt
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-20       Impact factor: 3.738

5.  Relationship between endothelial dysfunction and kidney disease.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-12-12       Impact factor: 3.738

6.  Masked hypertension as an unrecognized destructive condition.

Authors:  Sevket Balta; Mustafa Demir; Ugur Kucuk; Zekeriya Arslan; Sait Demirkol; Murat Unlu
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-12-12       Impact factor: 3.738

7.  Correlation between masked hypertension and endothelial dysfunction measured by flow-mediated dilation: a protocol of systematic review and meta-analysis.

Authors:  Xiaohua Zhang; Yong Li; Ling Gao; Qian Yu; Congliang Zhou; Wenshu Zou
Journal:  BMJ Open       Date:  2021-11-25       Impact factor: 2.692

8.  Masked hypertension defined by home blood pressure monitoring is associated with impaired flow-mediated vasodilatation in patients with cardiovascular risk factors.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-25       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.